Content

Grounded in original research, Jinfo Content helps you turn our insight into action on critical information challenges.

Available through a Jinfo Subscription, our articles, reports and recorded webinars bring you practical ideas, case studies, tips and models for change.

Filter the list below:

Article

Scott Vine Product review of DrugPatentWatch (technology - search & user interface; outputs & alerts; administration)
23rd January 2018

The third part of Jinfo's product review of DrugPatentWatch, a database which provides actionable business intelligence on small-molecule drugs, we highlight the search interface and functionality, provide a detailed look at the content and sources available in the product, typical use-cases as well as outputs and alerts available and its administrative capabilities.

Note: Full review (PDF) at /go/sub/report/2934

Read

Article

Scott Vine Product review of DrugPatentWatch (sources - content & coverage)
22nd January 2018

In part two of our product review of DrugPatentWatch, a database which provides patent information from the US and worldwide along with other actionable business intelligence on small-molecule drugs, we take a look at its strengths and weaknesses and content and sources.

Note: Full review (PDF) at /go/sub/report/2934

Read

Article

Sam Luton Building the mosaic - resources used inside buy-side funds to support the investment process
19th January 2018

The process of building an investment case within a buy-side fund is often thought of as being like piecing together a mosaic from many tiny fragments of information. This article provides a whistle-stop tour through a range of resources commonly used by firms to help their analysts find the relevant pieces.

Read

Article

Scott Vine Product review of DrugPatentWatch (key advantages; introduction; contact details)
19th January 2018

We carry out an in-depth product review of DrugPatentWatch, a database which provides actionable business intelligence on small-molecule drugs and patents and was founded by Yali Friedman, named one of the 100 most influential people in biotechnology. Part one of the review introduces the product and company behind it, along with its key advantages, competitors and how the product is likely to evolve.

Note: Full review (PDF) at /go/sub/report/2934

Read

Report
Article

Andrew Lucas Is service reengineering part of your 2018 strategy?
18th January 2018

Jinfo recently held its annual State of the industry Community session where participants discussed their top concerns for the coming year. This article brings together insights and practical tips from the session and also explores some of the themes we'll be looking at in an upcoming Research Focus, "The information team with the right stuff", including the likely impact on training and continuous professional development of information professionals.

Read

Webinar